NEW YORK (GenomeWeb) – The United States Court of Appeals for the Federal Circuit today issued a ruling upholding a judgement from the Patent Trial and Appeal Board (PTAB) which gave the Broad Institute and its partners control of key CRISPR genome editing patents and left the University of California and its co-litigants in the cold.